These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 12430715)

  • 41. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
    Jana NR; Nukina N
    J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation.
    Mattsson K; Pokrovskaja K; Kiss C; Klein G; Szekely L
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1012-7. PubMed ID: 11158586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains.
    Villagra NT; Navascues J; Casafont I; Val-Bernal JF; Lafarga M; Berciano MT
    Neurobiol Dis; 2006 Jan; 21(1):181-93. PubMed ID: 16125395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing.
    Sun J; Xu H; Negi S; Subramony SH; Hebert MD
    J Neurosci Res; 2007 Aug; 85(11):2306-17. PubMed ID: 17526020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyglutamine-mediated aggregation and cell death.
    de Cristofaro T; Affaitati A; Feliciello A; Avvedimento EV; Varrone S
    Biochem Biophys Res Commun; 2000 Jun; 272(3):816-21. PubMed ID: 10860836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.
    Cabrera CM; Jiménez P; Concha A; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 2004 May; 63(5):446-52. PubMed ID: 15104675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ribosomal protein SA is a common component of neuronal intranuclear inclusions in polyglutamine diseases and Marinesco bodies.
    Yagita K; Sadashima S; Koyama S; Noguchi H; Hamasaki H; Sasagasako N; Honda H
    Neuropathology; 2024 Feb; 44(1):31-40. PubMed ID: 37340992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sharing of polyglutamine localization by the neuronal nucleus and cytoplasm in CAG-repeat diseases.
    Yamada M; Tan CF; Inenaga C; Tsuji S; Takahashi H
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):665-75. PubMed ID: 15541006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.
    Holmberg M; Duyckaerts C; Dürr A; Cancel G; Gourfinkel-An I; Damier P; Faucheux B; Trottier Y; Hirsch EC; Agid Y; Brice A
    Hum Mol Genet; 1998 May; 7(5):913-8. PubMed ID: 9536097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.
    Lafarga M; Berciano MT; Pena E; Mayo I; Castaño JG; Bohmann D; Rodrigues JP; Tavanez JP; Carmo-Fonseca M
    Mol Biol Cell; 2002 Aug; 13(8):2771-82. PubMed ID: 12181345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
    Nozaki K; Onodera O; Takano H; Tsuji S
    Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
    Perez MK; Paulson HL; Pendse SJ; Saionz SJ; Bonini NM; Pittman RN
    J Cell Biol; 1998 Dec; 143(6):1457-70. PubMed ID: 9852144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes.
    Jana NR; Dikshit P; Goswami A; Kotliarova S; Murata S; Tanaka K; Nukina N
    J Biol Chem; 2005 Mar; 280(12):11635-40. PubMed ID: 15664989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mechanisms to control degradation of polyglutamine-containing protein].
    Nakayama K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):906-8. PubMed ID: 15152500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation.
    Morton AJ; Lagan MA; Skepper JN; Dunnett SB
    J Neurocytol; 2000 Sep; 29(9):679-702. PubMed ID: 11353291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease.
    Wanderer J; Morton AJ
    Histochem Cell Biol; 2007 May; 127(5):473-84. PubMed ID: 17285342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
    Waelter S; Boeddrich A; Lurz R; Scherzinger E; Lueder G; Lehrach H; Wanker EE
    Mol Biol Cell; 2001 May; 12(5):1393-407. PubMed ID: 11359930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.
    Doss-Pepe EW; Stenroos ES; Johnson WG; Madura K
    Mol Cell Biol; 2003 Sep; 23(18):6469-83. PubMed ID: 12944474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.